Digital Pathology Market by Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Disease Diagnosis, Drug Discovery), End User (Pharmaceutical Companies, Hospitals) - Global Forecast to 2025

デジタルパソロジーの世界市場予測:製品別(人工知能、スキャナー、ソフトウェア、ストレージ)、種類別(ヒト、獣医)、用途別(遠隔相談、疾患診断、創薬)、エンドユーザー別(製薬会社、病院)

◆タイトル:Digital Pathology Market by Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Disease Diagnosis, Drug Discovery), End User (Pharmaceutical Companies, Hospitals) - Global Forecast to 2025
◆商品コード:HIT 2608
◆調査・発行会社:MarketsandMarkets
◆発行日:2020年3月30日
◆ページ数:169
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,650 ⇒換算¥598,900見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥704,900見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥863,900見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarkets社はデジタルパソロジーの世界市場が、2020年613.6百万ドルから2025年1,139.8百万ドルまで、年平均13.2%成長すると予測しています。本調査レポートでは、デジタルパソロジーの世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場動向、デジタルパソロジーにおける人工知能、製品別(人工知能、スキャナー、ソフトウェア、ストレージ)分析、種類別(ヒト、獣医)分析、用途別(遠隔相談、疾患診断、創薬)分析、エンドユーザー別(製薬会社、病院、研究機関)分析、地域別分析、競争状況、企業概要などを含め、次の構成でお届け致します。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場動向
・デジタルパソロジーにおける人工知能
・デジタルパソロジーの世界市場:製品別(人工知能、スキャナー、ソフトウェア、ストレージ)
・デジタルパソロジーの世界市場:種類別(ヒト、獣医)
・デジタルパソロジーの世界市場:用途別(遠隔相談、疾患診断、創薬)
・デジタルパソロジーの世界市場:エンドユーザー別(製薬会社、病院、研究機関)
・デジタルパソロジーの世界市場:地域別
・競争状況
・企業概要

“The digital pathology market is projected to grow at a CAGR of 13.2% during the forecast period (2020–2025).”
The global digital pathology market is projected to reach USD 1,139.8 billion by 2025 from USD 613.6 billion in 2020, at a CAGR of 13.2% during the forecast period. The key factors driving the growth of this market include the
increasing adoption of digital pathology to enhance lab efficiency, rising prevalence of cancer, growing application of digital pathology in drug development & companion diagnostics, and increasing initiatives by industry players. However, the high cost of digital pathology systems is expected to restrict market growth to a certain extent.

“Adoption of artificial intelligence is expected to increase during the forecast period.”
The adoption of AI in healthcare has been rising in recent years due to its ability to optimize clinical processes, thereby solving a variety of problems in the healthcare industry. AI helps patients receive correct diagnosis in a timely manner, maximize hospital efficiency, and reduce the waiting time for patients, thereby enhancing overall healthcare. AI helps in collecting, storing, and normalizing data along with tracing its lineage.

“The software segment will grow at the highest rate during the forecast period.”
On the basis of product, the digital pathology market is segmented into scanners, software, communication systems, and storage systems. The scanners segment accounted for the largest share of the digital pathology market in 2019. The large share of this segment is mainly due to the increasing adoption of digital pathology solutions across the globe, and the high cost of scanners. On the other hand, the software segment is projected to witness the highest growth rate during the forecast period, due to the availability of user-friendly, analytical, and advanced functions for pathology diagnosis.

“By type, the human pathology segment accounted for the largest share of the digital pathology market in 2019.”
On the basis of type, the global digital pathology market is segmented into human and veterinary pathology. The human pathology segment accounted for the largest share of the digital pathology market in 2019. The increasing number of cancer research activities and growing collaborations between academic research institutes, universities, and pathology laboratories are driving the increased uptake of digital systems in human pathology.

“The market in North America is projected to witness the highest growth rate during the forecast period (2020–2025).”
North America is projected to register the highest growth during the forecast period. This large share can be attributed to factors such as the rising prevalence of cancer and increasing initiatives by industry players. On the other hand, the Asia Pacific region is expected to grow at the second-highest CAGR during the forecast period. Factors such as a large patient population, shortage of pathologists, increasing initiatives in the healthcare industry by key market players, and rising adoption of advanced technologies for disease diagnosis are driving the growth of the digital pathology market in this region.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type (Supply-side): Tier 1: 29%, Tier 2: 37%, and Tier 3: 34%
• By Category (Demand-side): Pharmaceutical & Biotechnology Companies: 55%, Hospitals and Reference Laboratories: 35%, and Academic & Research Institutes: 10%
• By Designation: C-level: 35%, Director-level: 25%, and Managers: 40%
• By Region: North America: 35%, Europe: 32%, Asia: 22%, and the RoW: 11%

Leica Biosystems (US), Koninklijke Philips (Netherlands), and Hamamatsu Photonics K.K. (Japan) are the leading players in the global digital pathology market. Other notable players in this market include Roche (Switzerland), 3DHISTECH (Hungary), Apollo Enterprise Imaging (US), XIFIN (US), Huron Digital Pathology (Canada), Visiopharm A/S (Denmark), Corista (US), Indica Labs (US), Objective Pathology Services (Canada), Sectra AB (Sweden), OptraSCAN (India), Glencoe Software (US), KONFOONG BIOTECH INTERNATIONAL CO., LTD (China), Inspirata Inc. (US), Mikroscan Technologies (US), Proscia Inc. (US), and Kanteron Systems (Spain).

Research Coverage:
The report analyzes the digital pathology market and aims at estimating the market size and future growth potential of this market based on various segments such as product, type, application, end user, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.

Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies.

This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the digital pathology market. The report analyzes the market based on the product, type, application, end user, and region.
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the digital pathology market.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of digital pathology solutions across regions.
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the digital pathology market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the digital pathology market.

【レポートの目次】

1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Break down of primary sources
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS
4.1 DIGITAL PATHOLOGY MARKET OVERVIEW
4.2 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT (2019)
4.3 GEOGRAPHICAL SNAPSHOT OF THE DIGITAL PATHOLOGY MARKET

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing adoption of digital pathology to enhance lab efficiency
5.2.1.2 Rising prevalence of cancer
5.2.1.3 Growing applications of digital pathology in drug development and companion diagnostics
5.2.1.4 Increasing initiatives by industry players
5.2.2 RESTRAINTS
5.2.2.1 High cost of digital pathology systems
5.2.3 OPPORTUNITIES
5.2.3.1 Introduction of affordable scanners for private pathology practices
5.2.3.2 Increase in demand for personalized medicines
5.2.3.3 High scope of growth in emerging economies
5.2.4 CHALLENGES
5.2.4.1 Lack of trained pathologists

6 ARTIFICIAL INTELLIGENCE IN DIGITAL PATHOLOGY

7 DIGITAL PATHOLOGY MARKET, BY PRODUCT
7.1 INTRODUCTION
7.2 SCANNERS
7.2.1 SCANNERS ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET IN 2019
7.2.2 BRIGHTFIELD SCANNERS
7.2.3 FLUORESCENCE SCANNERS
7.2.4 OTHER SCANNERS
7.3 SOFTWARE
7.3.1 DIGITAL PATHOLOGY SOFTWARE OFFER ANALYTICAL AND HIGHLY ADVANCED FUNCTIONS NOT OFFERED BY TRADITIONAL MICROSCOPES
7.3.2 INFORMATION MANAGEMENT SOFTWARE
7.3.3 IMAGE ANALYSIS SOFTWARE
7.3.4 VISUALIZATION SOFTWARE
7.4 COMMUNICATION SYSTEMS
7.4.1 INTRODUCTION OF CLOUD-BASED COMMUNICATION SYSTEMS PROVIDES IMPETUS TO MARKET GROWTH
7.5 STORAGE SYSTEMS
7.5.1 APPLICATION OF PACS AND VNA TO DRIVE THE STORAGE SYSTEMS MARKET

8 DIGITAL PATHOLOGY MARKET, BY TYPE
8.1 INTRODUCTION
8.2 HUMAN PATHOLOGY
8.2.1 HUMAN PATHOLOGY SEGMENT HELD THE LARGEST SHARE OF THE MARKET IN 2019
8.3 VETERINARY PATHOLOGY
8.3.1 VETERINARY DIGITAL PATHOLOGY CUTS THE TURNAROUND TIME FOR ANIMAL DISEASE DIAGNOSIS—A KEY FACTOR DRIVING MARKET GROWTH

9 DIGITAL PATHOLOGY MARKET, BY APPLICATION
9.1 INTRODUCTION
9.2 DRUG DISCOVERY
9.2.1 INCREASES IN R&D SPENDING WILL PROVIDE IMPETUS TO DRUG DISCOVERY SEGMENT DURING THE FORECAST PERIOD.
9.3 DISEASE DIAGNOSIS
9.3.1 DISEASE DIAGNOSIS SEGMENT TO REGISTER STEADY GROWTH DURING THE FORECAST PERIOD.
9.4 TELECONSULTATION
9.4.1 THE NEED FOR ACCURATE, EFFICIENT, AND QUICK DIAGNOSIS IS EXPECTED TO DRIVE THE TELECONSULTATION MARKET DURING THE FORECAST PERIOD
9.5 TRAINING & EDUCATION
9.5.1 DIGITAL PATHOLOGY CAN IMPROVE DISTRIBUTION OF RARE AND EDUCATIONAL CASES FOR TRAINING

10 DIGITAL PATHOLOGY MARKET, BY END USER
10.1 INTRODUCTION
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT IS ESTIMATED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST
10.3 HOSPITALS & REFERENCE LABORATORIES
10.3.1 INCREASING ADOPTION OF DIGITAL PATHOLOGY SOLUTIONS IN HOSPITALS TO DRIVE THE GROWTH OF THIS END-USER SEGMENT
10.4 ACADEMIC & RESEARCH INSTITUTES
10.4.1 ACADEMIC & RESEARCH INSTITUTES SEGMENT TO REGISTER STEADY GROWTH DURING THE FORECAST PERIOD

11 GLOBAL DIGITAL PATHOLOGY MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 US
11.2.1.1 Favorable reimbursement scenario for digital pathology in the US
11.2.2 CANADA
11.2.2.1 Growing need for high-quality cancer diagnosis and government initiatives to drive the market growth in Canada
11.3 EUROPE
11.3.1 UK
11.3.1.1 The UK to account for the largest share in the European market
11.3.2 GERMANY
11.3.2.1 High healthcare expenditure and supportive health insurance to drive the market growth in Germany
11.3.3 SWEDEN
11.3.3.1 Increasing government initiatives and deployment of digital pathology solutions
11.3.4 DENMARK
11.3.4.1 High cancer prevalence to drive the market growth in Denmark
11.3.5 FRANCE
11.3.5.1 Increasing incidences of cancer to drive the market growth during the forecast period
11.3.6 REST OF EUROPE (ROE)
11.3.6.1 Integration & deployment of digital pathology solutions in Rest of Europe
11.4 ASIA PACIFIC
11.4.1 CHINA
11.4.1.1 Favorable initiatives for the adoption of telepathology in China
11.4.2 JAPAN
11.4.2.1 Initiatives are taken by industry players for cancer diagnosis
11.4.3 INDIA
11.4.3.1 Increasing incidences of cancer in India to drive the market growth
11.4.4 REST OF ASIA PACIFIC (ROAPAC)
11.5 REST OF THE WORLD
11.5.1 LATIN AMERICA
11.5.1.1 Increase in purchasing power and healthcare affordability to drive the market growth in LATAM countries
11.5.2 MIDDLE EAST AND AFRICA
11.5.2.1 Potential for the growth of the digital pathology market in this region

12 COMPETITIVE LANDSCAPE
12.1 INTRODUCTION
12.2 MARKET SHARE ANALYSIS
12.3 COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET) (2019)
12.3.1 VISIONARY LEADERS
12.3.2 INNOVATORS
12.3.3 DYNAMIC DIFFERENTIATORS
12.3.4 EMERGING COMPANIES
12.4 COMPETITIVE SCENARIO
12.4.1 KEY DEVELOPMENTS IN THE DIGITAL PATHOLOGY MARKET
12.4.2 KEY PRODUCT LAUNCHES
12.4.3 KEY ACQUISITIONS
12.4.4 KEY EXPANSIONS

13 COMPANY PROFILES
(Business overview, Products offered, Recent developments, Competitive analysis)*
13.1 LEICA BIOSYSTEMS (SUBSIDIARY OF DANAHER CORPORATION)
13.2 KONINKLIJKE PHILIPS
13.3 HAMAMATSU PHOTONICS
13.4 F. HOFFMANN-LA ROCHE LTD
13.5 SECTRA AB
13.6 3DHISTECH
13.7 APOLLO ENTERPRISE IMAGING
13.8 XIFIN, INC.
13.9 HURON DIGITAL PATHOLOGY
13.10 VISIOPHARM
13.11 CORISTA
13.12 INDICA LABS
13.13 OBJECTIVE PATHOLOGY SERVICES
13.14 OPTRASCAN, INC.
13.15 GLENCOE SOFTWARE, INC.
13.16 OTHER COMPANIES
13.16.1 KONFOONG BIOTECH INTERNATIONAL CO., LTD
13.16.2 INSPIRATA, INC.
13.16.3 MIKROSCAN TECHNOLOGIES, INC.
13.16.4 PROSCIA INC
13.16.5 KANTERON SYSTEMS
*Business overview, Products offered, Recent developments, Competitive analysis might not be captured in case of unlisted companies.

14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 AVAILABLE CUSTOMIZATIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS

LIST OF TABLES (159 Tables)

TABLE 1 GLOBAL CANCER INCIDENCE, 2018 VS. 2025
TABLE 2 GROWTH IN THE NUMBER OF PERSONALIZED MEDICINES, 2008–2016
TABLE 3 NUMBER OF PATHOLOGISTS PER 100,000 POPULATION, BY COUNTRY, 2018
TABLE 4 DIGITAL PATHOLOGY AI MARKET, BY REGION, 2018–2025 (MILLION)
TABLE 5 DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 6 SCANNING MAGNIFICATION AND APPLICATIONS
TABLE 7 DIGITAL PATHOLOGY SCANNERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 8 DIGITAL PATHOLOGY SCANNERS MARKET, BY REGION, 2018–2025 (UNITS)
TABLE 9 DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 10 BRIGHTFIELD SCANNERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 11 FLUORESCENCE SCANNERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 12 OTHER SCANNERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 13 TYPES OF DIGITAL PATHOLOGY SOFTWARE
TABLE 14 DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 15 INFORMATION MANAGEMENT SOFTWARE MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 16 IMAGE ANALYSIS SOFTWARE MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 17 VISUALIZATION SOFTWARE MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 18 COMMUNICATION SYSTEMS USED IN DIGITAL PATHOLOGY
TABLE 19 DIGITAL PATHOLOGY COMMUNICATION SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 20 DIGITAL PATHOLOGY STORAGE SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 21 DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 22 HUMAN DIGITAL PATHOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 23 VETERINARY DIGITAL PATHOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 24 DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 25 APPLICATIONS OF DIGITAL PATHOLOGY IN DRUG DISCOVERY/RESEARCH:
TABLE 26 DIGITAL PATHOLOGY MARKET FOR DRUG DISCOVERY, BY REGION, 2018–2025 (USD MILLION)
TABLE 27 DIGITAL PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY REGION, 2018–2025 (USD MILLION)
TABLE 28 DIGITAL PATHOLOGY MARKET FOR TELECONSULTATION, BY REGION, 2018–2025 (USD MILLION)
TABLE 29 DIGITAL PATHOLOGY MARKET FOR TRAINING & EDUCATION, BY REGION, 2018–2025 (USD MILLION)
TABLE 30 DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 31 DIGITAL PATHOLOGY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 32 HOSPITAL DEPLOYMENT OF DIGITAL PATHOLOGY SOLUTIONS
TABLE 33 DIGITAL PATHOLOGY MARKET FOR HOSPITALS & REFERENCE LABORATORIES, BY REGION, 2018–2025 (USD MILLION)
TABLE 34 DIGITAL PATHOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018–2025 (USD MILLION)
TABLE 35 DIGITAL PATHOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 36 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 37 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 38 NORTH AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 39 NORTH AMERICA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 40 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 41 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 42 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 43 CANCER CASES IN THE US, 2018
TABLE 44 CONFERENCES/MEETINGS/COURSES/WORKSHOPS HELD/TO BE HELD IN THE US
TABLE 45 US: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 46 US: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 47 US: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 48 US: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 49 US: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 50 US: DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 51 CANADA: DIGITAL PATHOLOGY INITIATIVES AND FUNDING
TABLE 52 CANADA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 53 CANADA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 54 CANADA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 55 CANADA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 56 CANADA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 57 CANADA: DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025(USD MILLION)
TABLE 58 EUROPE: DIGITAL PATHOLOGY MARKET, BY COUNTRY/REGION, 2018–2025 (USD MILLION)
TABLE 59 EUROPE: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 60 EUROPE: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 61 EUROPE: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 62 EUROPE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 63 EUROPE: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 64 EUROPE: DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 65 CONFERENCES/COURSES HELD/TO BE HELD IN THE UK
TABLE 66 UK: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 67 UK: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 68 UK: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 69 UK: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 70 UK: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 71 UK: DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 72 CANCER INCIDENCE, BY TYPE, 2018 VS. 2025
TABLE 73 GERMANY: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 74 GERMANY: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 75 GERMANY: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 76 GERMANY: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 77 GERMANY: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 78 GERMANY: DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 79 CANCER CASES IN SWEDEN, 2018
TABLE 80 SWEDEN: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025(USD MILLION)
TABLE 81 SWEDEN: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 82 SWEDEN: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 83 SWEDEN: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 84 SWEDEN: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 85 SWEDEN: DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 86 DENMARK: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 87 DENMARK: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 88 DENMARK: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 89 DENMARK: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 90 DENMARK: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 91 DENMARK: DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 92 CANCER INCIDENCE, BY TYPE, 2018 VS. 2025
TABLE 93 FRANCE: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 94 FRANCE: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 95 FRANCE: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 96 FRANCE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 97 FRANCE: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 98 FRANCE: DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 99 ROE: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 100 ROE: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 101 ROE: DIGITAL PATHOLOGY SOFTWARE MARKET, BY SOFTWARE, 2018–2025 (USD MILLION)
TABLE 102 ROE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 103 ROE: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 104 ROE: DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 105 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 106 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 107 ASIA PACIFIC: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 108 ASIA PACIFIC: DIGITAL PATHOLOGY SOFTWARE MARKET, BY SOFTWARE, 2018–2025 (USD MILLION)
TABLE 109 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 110 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 111 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 112 CANCER CASES IN CHINA, 2018
TABLE 113 CHINA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 114 CHINA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 115 CHINA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 116 CHINA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 117 CHINA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 118 CHINA: DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 119 JAPAN: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 120 JAPAN: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 121 JAPAN: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 122 JAPAN: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 123 JAPAN: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 124 JAPAN: DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 125 INDIA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 126 INDIA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 127 INDIA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 128 INDIA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 129 INDIA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 130 INDIA: DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 131 ROAPAC: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 132 ROAPAC: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 133 ROAPAC: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 134 ROAPAC: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 135 ROAPAC: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 136 ROAPAC: DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 137 ROW: DIGITAL PATHOLOGY MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 138 ROW: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 139 ROW: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 140 ROW: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 141 ROW: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 142 ROW: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 143 ROW: DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 144 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 145 LATIN AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 146 LATIN AMERICA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 147 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 148 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 149 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 150 MIDDLE EAST AND AFRICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 151 MIDDLE EAST AND AFRICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 152 MIDDLE EAST AND AFRICA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 153 MIDDLE EAST AND AFRICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 154 MIDDLE EAST AND AFRICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 155 MIDDLE EAST AND AFRICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 156 PARTNERSHIPS AND COLLABORATIONS (2016–2019)
TABLE 157 PRODUCT LAUNCHES (2016–2019)
TABLE 158 ACQUISITIONS (2016–2019)
TABLE 159 EXPANSIONS (2016–2019)

LIST OF FIGURES (26 Figures)

FIGURE 1 RESEARCH DESIGN
FIGURE 2 PRIMARY SOURCES
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY CATEGORY, DESIGNATION, AND REGION
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 5 ILLUSTRATIVE EXAMPLE OF LEICA BIOSYSTEMS (SUBSIDIARY OF DANAHER CORPORATION)
FIGURE 6 DATA TRIANGULATION METHODOLOGY
FIGURE 7 DIGITAL PATHOLOGY MARKET ANALYSIS, BY PRODUCT (2020)
FIGURE 8 DIGITAL PATHOLOGY MARKET ANALYSIS, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 9 DIGITAL PATHOLOGY MARKET ANALYSIS, BY APPLICATION, 2020 VS. 2025, (USD MILLION)
FIGURE 10 DIGITAL PATHOLOGY MARKET ANALYSIS, BY END USER, 2020 VS. 2025, (USD MILLION)
FIGURE 11 NORTH AMERICA MARKET TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 12 INCREASING ADOPTION OF DIGITAL PATHOLOGY SOLUTIONS TO DRIVE THE MARKET
FIGURE 13 SCANNERS ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN DIGITAL PATHOLOGY MARKET IN 2019
FIGURE 14 NORTH AMERICA TO WITNESS THE HIGHEST GROWTH IN THE DIGITAL PATHOLOGY MARKET FROM 2020 TO 2025
FIGURE 15 DIGITAL PATHOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 16 DIGITAL PATHOLOGY MARKET, BY REGION, 2019
FIGURE 17 NORTH AMERICA: DIGITAL PATHOLOGY MARKET SNAPSHOT
FIGURE 18 EUROPE: DIGITAL PATHOLOGY MARKET SNAPSHOT
FIGURE 19 CANCER PREVALENCE IN DENMARK
FIGURE 20 VALUE-BASED MARKET SHARES OF KEY PLAYERS, 2019
FIGURE 21 DIGITAL PATHOLOGY MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2019
FIGURE 22 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
FIGURE 23 KONINKLIJKE PHILIPS: COMPANY SNAPSHOT (2019)
FIGURE 24 HAMAMATSU PHOTONICS: COMPANY SNAPSHOT (2019)
FIGURE 25 F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT (2019)
FIGURE 26 SECTRA AB: COMPANY SNAPSHOT (2018)



★調査レポート[デジタルパソロジーの世界市場予測:製品別(人工知能、スキャナー、ソフトウェア、ストレージ)、種類別(ヒト、獣医)、用途別(遠隔相談、疾患診断、創薬)、エンドユーザー別(製薬会社、病院)] ( Digital Pathology Market by Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Disease Diagnosis, Drug Discovery), End User (Pharmaceutical Companies, Hospitals) - Global Forecast to 2025 / HIT 2608) 販売に関する免責事項
[デジタルパソロジーの世界市場予測:製品別(人工知能、スキャナー、ソフトウェア、ストレージ)、種類別(ヒト、獣医)、用途別(遠隔相談、疾患診断、創薬)、エンドユーザー別(製薬会社、病院)] ( Digital Pathology Market by Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Disease Diagnosis, Drug Discovery), End User (Pharmaceutical Companies, Hospitals) - Global Forecast to 2025 / HIT 2608) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆